Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted Non-Current Assets of $17.7 billion for Q2 2026, little changed on a QoQ basis from $17.8 billion in Q1 2026, and down 0.62% year-over-year from $17.8 billion in Q2 2025.
Analysis
Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Non-Current Assets for 18 years, with the latest figure at $17.7 billion in Q2 2026.
- On a quarterly basis, Non-Current Assets fell 0.62% year-over-year to $17.7 billion in Q2 2026; TTM through Jun 2026 was $71.1 billion, a 4.61% increase from a year earlier, with the FY2025 full-year figure at $18.0 billion, up 7.66% from the prior year.
- Non-Current Assets was $17.7 billion for Q2 2026 at Zimmer Biomet Holdings, roughly flat from $17.8 billion in the prior quarter.
- The five-year high for Non-Current Assets was $18.0 billion in Q4 2025, with the low at $16.6 billion in Q1 2025.
- Average Non-Current Assets over 5 years is $17.1 billion, with a median of $16.9 billion recorded in 2023.
- The sharpest annual moves came in 2022 and 2025: Non-Current Assets retreated 10.41% in 2022, then gained 7.66% in 2025.
- Over 5 years, Non-Current Assets stood at $16.6 billion in 2022, then grew by 1.49% to $16.9 billion in 2023, then dropped by 1.15% to $16.7 billion in 2024, then increased by 7.66% to $18.0 billion in 2025, then slipped by 1.51% to $17.7 billion in 2026.
- The last three Non-Current Assets figures came in at $17.7 billion (Q2 2026), $17.8 billion (Q1 2026), and $18.0 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 11.33 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 68.92 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 33.51 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 37.24 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 7.05 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 24.47 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 2.37 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Zimmer Biomet Holdings | 18.20 Bn | 17.79 Bn | 1.54 Bn | 17.70 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.70 Bn |
| Mar 31, 2026 | 17.76 Bn |
| Dec 31, 2025 | 17.97 Bn |
| Sep 30, 2025 | 17.65 Bn |
| Jun 30, 2025 | 17.81 Bn |
| Mar 31, 2025 | 16.59 Bn |
| Dec 31, 2024 | 16.69 Bn |
| Sep 30, 2024 | 16.86 Bn |
| Jun 30, 2024 | 16.88 Bn |
| Mar 31, 2024 | 16.82 Bn |
| Dec 31, 2023 | 16.89 Bn |
| Sep 30, 2023 | 16.85 Bn |
| Jun 30, 2023 | 16.91 Bn |
| Mar 31, 2023 | 16.83 Bn |
| Dec 31, 2022 | 16.64 Bn |
| Sep 30, 2022 | 16.80 Bn |
| Jun 30, 2022 | 16.99 Bn |
| Mar 31, 2022 | 17.10 Bn |
| Dec 31, 2021 | 18.57 Bn |
| Sep 30, 2021 | 18.70 Bn |